Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro.

about

NTM drug discovery: status, gaps and the way forward.Teicoplanin - Tigecycline Combination Shows Synergy Against Mycobacterium abscessus.and β-Lactams: Emerging Insights and Potential Opportunities The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in Drug Resistance

P2860

Q52596288-CCE4F4BE-F0ED-4115-B9D1-0E5379F2AB0B Q55381713-B261E5C8-E26C-4E7D-9705-DE57DDC6618B Q57492057-CA5AD8D0-D2C1-4CF5-8605-3EF830A18945 Q58746601-E6B3B7EA-F437-47CD-814A-0D55A3CA9016

P2860

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro.

Item

http://www.wikidata.org/entity/Q47135489

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro.

@en

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro.

@nl

type

Item

label

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro.

@en

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro.

@nl

prefLabel

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro.

@en

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro.

@nl

P1476

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro

@en

P2093

Devika Mukherjee

http://www.w3.org/2001/XMLSchema#string

Mu-Lu Wu

http://www.w3.org/2001/XMLSchema#string

P2860

rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov

Rifabutin Is Active against Mycobacterium abscessus Complex.

Draft Genome Sequence of Mycobacterium abscessus Bamboo

Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.

Structure, biochemistry and mechanism of action of glycopeptide antibiotics.

Efficient differentiation of Mycobacterium abscessus complex isolates to the species level by a novel PCR-based variable-number tandem-repeat assay.

Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.

Mycobacterium abscessus: a new antibiotic nightmare.

P31

scholarly article

P356

10.1128/AAC.01298-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Dick

Jeanette Teo

P577

2017-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28923867

http://www.w3.org/2001/XMLSchema#string

P932

5700366

http://www.w3.org/2001/XMLSchema#string

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro.

about

P2860

P2860

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932